Journal of Veterinary Pharmacology and Therapeutics

Cover image for Vol. 39 Issue 6

Edited By: Jim E. Riviere, Manfred Kietzmann and Paul Mills

Impact Factor: 1.279

ISI Journal Citation Reports © Ranking: 2015: 38/138 (Veterinary Sciences); 207/255 (Pharmacology & Pharmacy)

Online ISSN: 1365-2885

Author Guidelines


The Journal of Veterinary Pharmacology and Therapeutics (JVPT) is an international journal devoted to the publication of scientific papers in the basic and clinical aspects of veterinary pharmacology and toxicology. The Journal is a forum for recent scientific information and developments in the discipline of veterinary pharmacology, including toxicology and therapeutics.

Ethical Guidelines

JVPT adheres to the below ethical guidelines for publication and research.

Authorship, Acknowledgements and Conflicts of Interest

JVPT adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE, authorship should be based on 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3. It is a requirement that all authors have been accredited as appropriate upon submission of the manuscript. Contributors who do not qualify as authors should be mentioned under Acknowledgements.

Authors submitting a paper do so on the understanding that the manuscript has been read and approved by all authors and that all authors agree to the submission of the manuscript to the journal. The number of authors is not limited for manuscripts submitted to JVPT, however, participation solely in the acquisition of funding or the collection of data does not justify authorship.

Acknowledgements ‒ under acknowledgements, please specify contributors to the article other than the authors accredited. Please also include specifications of the source of funding for the study. Suppliers of materials should be named and their location (town, state/county, country) included.

Conflicts of interest(s), including a null declaration, are a required section within papers that are submitted to JVPT. All papers must include full details of any conflicts of interest. Authors are required to disclose financial interests (e.g. employment, significant share ownership, patent rights, consultancy, research funding, etc.) in any company, organisation or institution that might benefit from their publication. A conflicting interest exists when a primary interest (such as patients’ welfare or the validity of research) might be influenced by a secondary interest (such as financial gain or personal rivalry). For example, a conflict of interest may arise for the authors of a paper when they have a financial interest that may influence their interpretation of their results; or may influence their views about the results of others. Of such conflicts of interest, financial interests are the easiest to define and they have the greatest potential to influence the objectivity, integrity or perceived value of a publication. For papers where there are no competing interests, the following statement must be included, ‘Conflicts of interest: the authors have no conflicts of interest’.

Animal Studies

All materials published in JVPT must adhere to high ethical standards concerning animal welfare.

Animal ethics-based criteria for manuscript consideration

Manuscripts will be considered for publication only if the work detailed therein:

1) Follows international, national, and/or institutional guidelines for humane animal treatment and complies with relevant legislation

2) Has been approved by the ethics review committee at the institution or practice at which the studies were conducted where such a committee exists

3) For studies using client-owned animals, demonstrates a high standard (best practice) of veterinary care and involves informed client consent

Prior to acceptance of a manuscript, to verify compliance with the above policies, the authors must specify in Materials and Methods the ethical review committee approval process and the international, national, and/or institutional guidelines followed.

Animal ethics-based criteria for manuscript rejection

1) Manuscripts and authors that fail to meet the aforementioned requirements

2) Studies that involve unnecessary pain, distress, suffering, or lasting harm to animals

3) The Editors retain the right to reject manuscripts on the basis of ethical or welfare concerns

Submission of Manuscripts

All manuscripts should be submitted online at A user ID and password are required and can be obtained on the first use of the site. Any articles submitted as a hardcopy will be returned to the authors for re-submission. Once you have submitted your manuscript, you will receive a confirmation email which will include your manuscript reference number. You can log onto the system at any time to track the progress of your manuscript.

If you have problems with your submission, please contact the Editorial Office. The Editors’ details are provided below:

Jim E. Riviere
The MacDonald Chair in Veterinary Medicine
and University Distinguished Professor
Institute of Computational Comparative Medicine
College of Veterinary Medicine
Manhattan, KS 66505-5802
Tel: +1785-532-3783

Manfred Kietzmann
Institut für Pharmakologie, Toxikologie und Pharmazie
Stiftung Tierärztliche Hochschule Hannover
Bünteweg 17
30559 Hannover
Tel: +49 (0)511 9538730
Fax: +49 (0)511 9538581

Paul Mills
Professor of Veterinary Pharmacology
School of Veterinary Sciences
Level 1, Veterinary Sciences Building (#8114)
The University of Queensland, Gatton Campus
Qld, 4343, Australia
Tel: +61 7 5460 1852

Review Editor

Mark Papich
Burroughs Wellcome Distinguished Professor of Veterinary Pharmacology
Department of Molecular Biomedical Sciences
North Carolina State University
College of Veterinary Medicine
1060 William Moore Drive
Raleigh, NC 27607

Presentation of Manuscripts

JVPT’s language is English. The original manuscript should be formatted with double line spacing using the letter type Arial or Times New Roman (12 pt) with continuing line numbers from the title page onwards. Line numbers are also requested for manuscripts submitted as PDF-files. Symbols (including Greek letters) have to be noted and explained with a separate list of abbreviations preceding the manuscript. Abbreviations should be defined the first time they are used (and may be explained in a footnote).

The title page should contain the full title and a short running title, author's full name(s), present affiliation, and address for correspondence and email address of the corresponding author.

Article Types

Scientific Papers

The abstract should not exceed 200 words and should include a list of 5 keywords. The main sections should follow the general outline of a scientific paper, starting with an Introduction, Materials and Methods, followed by Results and Discussion, Acknowledgements and References. These sections could be divided into sub-sections where appropriate.

Short Communications

These should differ from full papers on the basis of scope or completeness, rather than quality of data. They may report significant new data arising from problems with narrow, well-defined limits, or important findings that warrant rapid publication before broader studies are complete. The text should neither exceed 1,500 words nor be divided up into conventional sections. A standard abstract not to exceed 200 words is required and should include a list of five keywords. To aid rapid publication the Editors may undertake responsibility for correcting proofs. When submitting short communications, authors should make it clear that their work is to be treated as such.

Letters to the Editor

Letters to the Editor are accepted, and may be in response to issues arising from recently published articles, or short, free-standing pieces expressing an opinion. No abstract is required, and text should be formatted in one continuous section. Letters are limited to 1,000 words.


The journal welcomes reviews providing an updated state of the art on topics associated with Veterinary Pharmacology, Veterinary Therapy and Veterinary Toxicology. It is however recommended that authors who are planning or preparing larger review-type articles should contact the Review Editor for detailed information.

Mark Papich

Pharmacokinetic Reports

The aim of Pharmacokinetic Reports is to efficiently report on the pharmacokinetics of a drug from a defined study using a single dose by a single route of administration in a single species. More complex comparative studies (multiple doses, route comparisons, multiple species, and disease effects) would continue to be processed as full papers. The goal is to reduce lengthy introductions and discussions. The layout should be as follows:

  • Abstract - The abstract should not exceed 200 words.
  • Introduction - Introduce the drug class and provide a very short summary of the clinical applications.
  • Material and Methods – Overview of experimental design, analytical methods, pharmacokinetic modeling approach and software used and statistical criteria for optimal model selection.
  • Results - Provide both a table of pharmacokinetic parameters (without repeating parameters in the text) and plots of model predicted versus observed data or other graphical approaches to demonstrate model fit.
  • Discussion - Limit to 4-5 paragraphs, compare results to previous publications and briefly discuss implications of the analysis.
  • References - References should follow the format detailed below.
  • Supplemental Data - Provide individual raw data files to be published as supporting information alongside the article on the Journal of Veterinary Pharmacology and Therapeutics’ webpage on Wiley Online Library. Supplementary materials should be uploaded with the manuscript and labelled as ‘Supplementary File’.

Supplementary Materials

Supplementary materials are not proofed, so the contents should be considered final at the time the manuscript is accepted. Appendices will be treated as supplementary materials, so will be published online only as well. Supplementary files or appendices should be uploaded separately as Supplementary Material for Review.

Tables and figures

Tables and figures (including original images) should be presented on separate pages at the end of the manuscript, each with a clear (self-explaining) legend. Tables and figures should be referred to in the text together with an indication of their approximate position (mark with colour).

Authors must pay to have their figures reproduced in colour. Please submit the data for figures in black and white or submit a Colourwork Agreement Form.

Authors should post the hardcopy Colour Work Agreement (CWA) forms with original signature to Customer Services at the below address. Scanned or faxed versions of the forms should not be sent as that would be in contravention of Wiley’s PCI compliance policy.

Customer Services (OPI)
John Wiley & Sons Ltd, European Distribution Centre
New Era Estate
Oldlands Way
Bognor Regis
West Sussex
PO22 9NQ

Preparation of Electronic Figures for Publication

Although low quality images are adequate for review purposes, print publication requires high quality images to prevent the final product being blurred or fuzzy. Submit EPS (lineart) or TIFF (halftone/photographs) files only. MS PowerPoint and Word Graphics are unsuitable for printed pictures. Do not use pixel-oriented programmes. Scans (TIFF only) should have a resolution of 300 dpi (halftone) or 600 to 1200 dpi (line drawings) in relation to the reproduction size (see below). EPS files should be saved with fonts embedded (and with a TIFF preview if possible).

For scanned images, the scanning resolution (at final image size) should be as follows to ensure good reproduction: lineart: >600 dpi; half-tones (including gel photographs): >300 dpi; figures containing both halftone and line images: >600 dpi.

Further information can be obtained at Wiley’s guidelines for figures:

Check your electronic artwork before submitting it:

Abbreviations and Terminology

Spelling should conform to that of standard dictionaries (e.g. The Concise English Dictionary, Webster's New Collegiate Dictionary). Style should conform to that of standard manuals of English usage. Authors who are not fluent in English should seek skilled advice on the composition of their manuscripts.

Units of measurement, symbols and standard abbreviations should conform to those recommended by the International Union of Bio-Chemistry (IUB) and the International Union of Pure and Applied Chemistry (IUPAC). Metric measurements are preferred, and dosages should be expressed entirely in metric units (SI units).


The reference list should be in alphabetical order and include the full title thus:

  • Eddy, R.G. (1977) The use of cloprostenal in the treatment of no visible oestrus and cystic ovarian disease in dairy cows. Veterinary Record, 109, 62-65.
  • Moe, G.K. & Abildskov, J.A. (1980). Antiarrhythmic drugs. In The Pharmacological Basis of Therapeutics. 6th edn. Eds Gilman, A.G., Goodman, L.S. & Gilman. A. pp. 683-704. Macmillan, New York.

References in the text should cite the name of the author followed by the year of publication, e.g. (Brown, 1978). When reference is made to a work by two authors, both names should be given, e.g. (Brown & White, 1978): for three or more authors, the first name followed by et al. should be used, e.g. (Brown et al., 1978). Authors are responsible for the accuracy of their references. We recommend the use of a tool such as Reference Manager for reference management and formatting.

Reference Manager Reference styles can be searched for here:


Page proofs will be dispatched via e-mail notification of a link with a downloadable Acrobat PDF* (portable document format) file about 4 weeks after acceptance of papers and should be corrected and returned within 3 days of receipt. Only corrections and essential changes can be made at this stage. The cost of any extensive changes will be charged to the authors. The Editors reserve the right to make minor modifications to manuscripts that do not conform to accepted standards. Such alterations will always be submitted to the authors for approval at the proof stage. Online publication will normally be within 2 weeks of receipt of corrected proofs by the production office.


Free access to the final PDF offprint or your article will be available via Author Services. Please therefore sign up for Author Services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers.

Pre-submission English-language Editing

Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. A list of independent suppliers of editing services can be found here. All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.

Early View

Early View is Wiley's exclusive service presenting individual articles online as soon as they are ready before the release of the compiled print issue. Early View articles are complete, citable and are published in an average time of 6 weeks from acceptance.

Page charges

No page charges are levied on authors or their institutions.


If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions

For authors choosing OnlineOpen

If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

  • Creative Commons Attribution Non-Commercial License OAA
  • Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit

If you select the OnlineOpen option and your research is funded by certain funders [e.g.The Wellcome Trust and members of the Research Councils UK (RCUK) or the AustrianSceinceFund(FWF)] you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit:

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit

Online production tracking is now available for your article through Wiley’s Author Services.

Author Services enables authors to track their article – once it has been accepted – through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.